ASX Announcement 31August 2026 BCAL Diagnostics to host ‘Meet the CEO’ - FY26 Results webinar BCAL Diagnostics Limited (ASX: BDX, BCAL or Company) advises that Chief Executive Officer Anne- Louise Arnett and Chair Jayne Shaw will host a ‘Meet the CEO’ - FY26 Results webinar on: ...
Meet The CEO FY 2026 Results Webinar 3 Sept 2026 at 1PM
Filed with ASX · · 1 page · English
Summary by 6ix AI
The session will feature CEO Anne-Louise Arnett and Chair Jayne Shaw, providing insights into the company's recent operational and commercial progress. Investors will have the opportunity to ask questions following the presentation. The webinar is scheduled for a specific date and time in early September.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Appendix 4E and Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
- BCAL Takes Interest in Genetic Signatures to 18.46%
- Change in Substantial Shareholder Notice for GSS
- Notification regarding unquoted securities - BDX
Later from BCAL Diagnostics
- Investor Presentation September 2026
- BCAL Seeks Board Change at Genetic Signatures
- Clarification of BCAL's Position in Relation to GSS
- Notice of Annual General Meeting/Proxy Form
- Letter to Shareholders re Annual General Meeting
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics